A cost-benefit analysis of cholera vaccination programs in Beira, Mozambique

World Bank Economic Review

Volumn 23, Issue 2, 2009, Pages 235-267

  Jeuland, Marc ^a   Lucas, Marcelino ^b   Clemens, John ^c   Whittington, Dale ^a,d  

^a University of North Carolina at Chapel Hill   (United States)

^b Ministry of Science and Technology of Mozambique   (Mozambique)

^c International Vaccine Institute   (South Korea)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA; COST-BENEFIT ANALYSIS; DISEASE INCIDENCE; EPIDEMIOLOGY; HEALTH EXPENDITURE; IMMUNIZATION; PARAMETERIZATION; VACCINATION; WILLINGNESS TO PAY;

AFRICA; BEIRA; MOZAMBIQUE; SOFALA; SOUTHERN AFRICA; SUB-SAHARAN AFRICA;

DORCATRAGUS MEGALOTIS;

EID: 68249158086     PISSN: 02586770     EISSN: 1564698X     Source Type: Journal    
DOI: 10.1093/wber/lhp006     Document Type: Article

References (32)

1. Ahituv, A., V. Hotz, and T. Philipson. 1996. "The Responsiveness of the Demand for Condoms to the Local Prevalence of AIDS." The Journal of Human Resources 31(4):869-97.
2. Ali, M., M. Emch, L. von Seidlein, M. Yunus, D.A. Sack, M. Rao, J. Holmgren, and J. Clemens. 2005. "Herd Immunity Conferred by Killed Oral Cholera Vaccines in Bangladesh: A Reanalysis." The Lancet 366(9479):44-9.
3. Barua, D., and W.B. Greenough. 1992. Cholera. New York: Plenum.
4. Bhattacharya, Soma, Anna Alberini, and Maureen L. Cropper. 2007. "The Value of Mortality Risk Reductions in Delhi, India." Journal of Risk and Uncertainty 34(1):21-47.
5. Carson, R.T. 2000. "Contingent Valuation: A User's Guide." Environmental Science and Technology 34(8):1413-8.
6. Cookson, S.T., D. Stamboulian, J. Demonte, L. Quero, C.M. DeArquiza, A. Aleman, A. Lepetic, and M.M. Levine. 1997. "A Cost-Benefit Analysis of Programmatic Use of CVD 103-HgR Live Oral Cholera Vaccine in a High-Risk Population." International Journal of Epidemiology 26(1):212-9.
7. Deen, J.L., L. von Seidlein, D. Sur, M. Agtini, M.E.S. Lucas, A.L. Lopez, D.R. Kim, M. Ali, and J.D. Clemens. 2008. "The High Burden of Cholera in Children: Comparison of Incidence from Endemic Areas in Asia and Africa." PLoS Neglected Tropical Diseases 2(2):e173. doi:10.1371/journal.pntd.0000173.
8. Gersovitz, M. 2000. "A Preface to the Economic Analysis of Disease Transmission." Australian Economic Papers 39(1):68-83.
9. Gersovitz, M., and J. Hammer. 2003. "Infectious Diseases, Public Policy, and the Marriage of Economics and Epidemiology." The World Bank Research Observer 18(2):129-57.
10. Hanemann, W.M. 1994. "Valuing the Environment through Contingent Valuation." Journal of Economic Perspectives 8(4):19-43.
11. Jamison, D., J. Breman, A. Measham, G. Alleyne, M. Claeson, D.B. Evans, P. Jha, A. Mills, and P. Musgrove eds. 2006. Disease Control Priorities in Developing Countries. New York: Oxford University Press.
12. Jeuland, M., M. Lucas, J. Deen, N. Lazaro, and D. Whittington. 2008. "Estimating the Private Benefits of Vaccination against Cholera Using Travel Costs." Working Paper. Department of Environmental Sciences and Engineering, University of North Carolina, Chapel Hill.
13. Lauria, D., and J. Stewart. 2008. "The Costs of Vaccination Programs." Working Paper. Department of Environmental Sciences and Engineering University of North Carolina, Chapel Hill.
14. Lauria, D.T., B. Maskery, C. Poulos, and D. Whittington. 2009. "An Optimization Model for Reducing Typhoid Cases in Developing Countries without Increasing Public Spending." Vaccine 27(10):1609-21.
15. Longini, I.M., A. Nizam, M. Ali, M. Yunus, N. Shenvi, and J.D. Clemens. 2007. "Controlling Endemic Cholera with Oral Vaccines." PLoS Medicine 4(11):1776-83.
16. Lucas, M., M. Jeuland, M. MacMahon, D. Whittington, and A. Nyamete. 2007. "Private Demand for Cholera Vaccines in Beira, Mozambique." Vaccine 25(14):2599-609.
17. Lucas, M.E.S., J.L. Deen, L. von Seidlein, X.-Y. Wang, J. Ampuero, M. Puri, and M. Ali and others. 2005. "Effectiveness of Mass Oral Cholera Vaccination in Beira, Mozambique." New England Journal of Medicine 352(8):757-67.
18. Maskery, B., Z. Islam, J. Deen, and D. Whittington. 2008. "An Estimate of the Economic Value That Parents in Rural Bangladesh Place on Ex-ante Mortality Risk Reductions for Their Children." Working Paper. Department of Environmental Sciences and Engineering, University of North Carolina, Chapel Hill.
19. Murray, J., D.A. McFarland, and R.J. Waldman. 1998. "Cost-Effectiveness of Oral Cholera Vaccine in a Stable Refugee Population at Risk for Epidemic Cholera and in a Population with Endemic Cholera." Bulletin of the World Health Organization 76(4):343-52.
20. Naficy, A., M.R. Rao, C. Paquet, D. Antona, A. Sorkin, and J.D. Clemens. 1998. "Treatment and Vaccination Strategies to Control Cholera in Sub-Saharan Refugee Settings - A Cost-Effectiveness Analysis." Jama-Journal of the American Medical Association 279(7):521-5.
21. Naidoo, A., and K. Patric. 2002. "Cholera: A Continuous Epidemic in Africa." The Journal of the Royal Society for the Promotion of Health 122(2):89.
22. Philipson, T. 1996. "Private Vaccination and Public Health: An Empirical Examination for U.S. Measles." The Journal of Human Resources 31(3):611-30.
23. Poulos, C., A. Riewpaiboon, J.F. Stewart, A. Nyamete, S. Guh, J. Clemens, and S. Chatterjee and others.2008. "Costs of Illness Due to Endemic Cholera." Working Paper. Research Triangle Institute, Research Triangle Park, NC.
24. Ryan, E.T. 2000. "Mortality, Morbidity, and Microbiology of Endemic Cholera among Hospitalized Patients in Dhaka, Bangladesh." The American Journal of Tropical Medicine and Hygiene 63(1):12-20.
25. Sack, D.A., R.B. Sack, G.B. Nair, and A.K. Siddique. 2004. "Cholera." The Lancet 363(9404):223-33.
26. Sinha, A., O. Levine, M.D. Knoll, F. Muhib, and T.A. Lieu. 2007. "Cost-Effectiveness of Pneumococcal Conjugate Vaccination in the Prevention of Child Mortality: An International Economic Analysis." The Lancet 369(9559):389-95.
27. Thiem, V.D., J.L. Deen, L. von Seidlein, D.G. Canh, D.D. Anh, and J.K. Park. 2006. "Long-Term Effectiveness against Cholera of Oral Killed Whole-Cell Vaccine Produced in Vietnam." Vaccine 24(20):4297-303.
28. Trach, D., J. Clemens, N. Ke, H. Thuy, N. Son, D.G. Canh, P.V. Hang, and M.R. Rao. 1997. "Field Trial of a Locally Produced, Killed, Oral Cholera Vaccine in Vietnam." The Lancet 349(9047):231-5.
29. UNICEF (United Nations Children's Fund). 2003. Reference Vaccine Price List. New York (www.unicef.org/supply/index_immunization.html).
30. Whittington, D., O. Matsui-Santana, J.J. Freiberger, G. Van Houtven, and S. Pattanayak. 2002. "Private Demand for a HIV/AIDS Vaccine: Evidence from Guadalajara, Mexico." Vaccine 20(19/20): 2585-91.
31. Whittington, D., D. Sur, J. Cook, S. Chatterjee, B. Maskery, M. Lahiri, C. Poulos, and others. 2009. Rethinking cholera and typhoid vaccination policies for the poor: Private demand in Kolkata, India. World Development 37(2):399-409.
32. WHO (World Health Organization). 2005. "Cholera, 2004." Weekly Epidemiological Record 80(31):261-8.